Analytical Data
-
基因名
KIAA1143
- Application
-
别名
KIAA1143; Uncharacterized protein KIAA1143
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96AT1
-
表达区间
1-154aa
-
氨基酸序列
MSKRNQVSYVRPAEPAFLARFKERVGYREGPTVETKRIQPQPPDEDGDHSDKEDEQPQVVVLKKGDLSVEEVMKIKAEIKAAKADEEPTPADGRIIYRKPVKHPSDEKYSGLTASSKKKKPNEDEVNQDSVKKNSQKQIKNSSLLSFDNEDENE
-
分子量
43.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KIAA1143 is a protein that has garnered attention in the field of molecular biology and cancer research due to its potential implications in cellular functions and disease mechanisms. Initially identified through genomic studies, the KIAA family of proteins is known for their diverse roles in cellular processes, including cell proliferation, differentiation, and apoptosis. Recent studies have suggested that KIAA1143 may be involved in the regulation of the cell cycle and DNA repair mechanisms, which are critical for maintaining genomic stability. Alterations in the expression levels or mutations of KIAA1143 have been implicated in various cancers, making it a candidate for further investigation in the context of tumor biology. Researchers are particularly interested in characterizing the recombinant form of KIAA1143, as understanding its structural and functional properties could reveal insights into its biological roles. Recombinant protein studies may help elucidate its interactions with other cellular molecules and pathways, as well as its potential as a therapeutic target. As the understanding of KIAA1143 advances, it may pave the way for novel approaches in cancer treatment and biomarker discovery, highlighting the significance of this protein in both basic research and clinical applications. Overall, the exploration of KIAA1143 through recombinant protein technology represents a promising avenue for unraveling its biological significance and therapeutic potential.












